CNBC's "Fast Money"
SpaceX on the move in after-hours trading on the back of its first earnings report since going public. Can investors expect SpaceX to blast off, or will the aerospace giant sink even further below its IPO price?Then, major Pharma earnings from giants like Pfizer and Merck beating Wall Street estimates with Amgen and Eli Lilly on deck. Founder and CEO of Portal Innovations John Flavin lays out the best trades in the Pharma market, and his reaction to Novo Nordisk’s slide after disappointing guidance. Plus, why Morgan Stanley is bearish on AMD, digging into Caterpillar earnings, and can McDonald’s make a comeback? Fast Money Disclaimer [https://www.cnbc.com/fast-money-disclaimer/] Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com [https://pcm.adswizz.com] for information about our collection and use of personal data for advertising.
300 jaksot
Kommentit
0Ole ensimmäinen kommentoija
Rekisteröidy nyt ja liity CNBC's "Fast Money"-yhteisöön!